Tuesday, October 28, 2014
FDA grants breakthrough therapy status for Merck's lung cancer drug Keytruda
… patients with advanced non-small cell lung cancer (NSCLC).
Keytruda is a humanized … approaches for advanced non-small cell lung cancer continue to be needed.
… and III trials in advanced lung cancer (KEYNOTE-010 and KEYNOTE-024) and an …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment